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Abstract:
The incidence of Type 1 Diabetes (T1D) is increasing worldwide and is diagnosed
disproportionately in adolescent populations1,2,3. Additionally, studies show that adolescents with
T1D experience worse glycemic control during this developmental period6,13,15,18. Maintaining
glycemic control in patients with T1D decreases the risk of developing future diabetic-related
complications3,6,14. Factors such as race, ethnicity, gender identity, sexual orientation,
socioeconomic status, and medical comorbidities influence disparities in maintaining glycemic
control in adolescents6,11,12,13,15, 17. The recognition of these factors on the management of T1D
through an integrative team approach leads to increased glycemic control and decreased diabeticrelated complications6,15,19,20,21. This paper explores the effects of psychosocial factors and
addresses recommendations for effective interventions through multidisciplinary care. The
literature reviewed in this paper indicates that improving healthcare access, implementing
behavioral interventions, and increasing the use of diabetic technologies in adolescent
populations have improved glycemic control and decrease disparities in healthcare outcomes. A
multidisciplinary team increases patient education and aids in managing and screening for
comorbidities. Team-based management of T1D also provides behavioral specialists that can
implement strategies that improve self-management skills and familial involvement15, 21,30,35,43.
Modern diabetic technology has given patients the tools to increase their healthcare access. It has
been shown to improve their self-management skills and has allowed providers to individualize
treatment plans further using data analytic software48,49,50. Improving glycemic control in
adolescence relies on physical and emotional support from healthcare providers and caregivers.
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Introduction:
The incidence of Type 1 Diabetes Mellitus (T1D) has been increasing at a rate of 3-4%
globally since the 1950s 1. This increase is of particular concern to individuals younger than 18
years of age as this population has seen the highest increase in incidence, and the majority of
diagnoses made are between 10-14 years of age1. The U.S. has one of the highest incidences of
T1D worldwide and is one of the most common endocrine disorders in children and adolescents,
currently affecting 200,000 people under the age of 205. T1D impacts those diagnosed and their
caregivers financially, physically, and emotionally2,6. In order to maintain a physiologically
normal blood glucose level, patients make an additional 180 decisions per day by evaluating
glycemic levels using self-monitored blood glucose checks (SMBG) and adjusting insulin doses
based on food intake and activity level1,6. To assess glycemic control in a patient, providers
monitor hemoglobin A1c values (HbA1c), which indicate the average blood glucose levels
throughout three months6. To avoid future diabetic-related complications, the American Diabetes
Association recommends that HbA1c goals be between 7.0-7.5% for patients with T1D between
13-19 years old6.
The ability to maintain adequate glycemic control within the individualized parameters
determined by the healthcare provider is well-established as the chief influence in preventing
complications related to T1D2,3. Complications of T1D are typically microvascular and
macrovascular complications requiring rigorous lifelong management and countless medical
supplies. Patients with T1D are immunocompromised and at higher risk for additional
autoimmune disorders and mental health disorders, which can compromise glycemic control and
add to the difficulty of treatment management11,12,13,28. Overall, patients with diabetes have a
younger age for mortality than the general population14. According to a retrospective cohort
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study from 2015, the mortality rate for patients with T1D in the U.S. is 5-7 times higher than the
mortality rate in other developed countries14. Adolescent patients with T1D are of particular
concern because studies have shown that glycemic control is likely to deteriorate during this
developmental period and can contribute to further complications in the future3,13,14,16,17. Older
adult populations are typically diagnosed with T1D-related complications. This pattern is
attributed to the direct relationship between the duration of the disease and the development of
diabetic-related pathologies, suggesting that avoiding complications of T1D relies on the
implementation of prevention strategies in younger age groups7. In addition to the increase in the
prevalence of T1D in adolescent populations, studies show that patients in this age group
experience a decline in glycemic control,

-risk

T1D5,6,15,18. Therefore, improving care in this population
may reduce future morbidity and mortality rates for all patients with T1D.
A

elopment

between childhood and adulthood, specific age-based definitions vary depending on sources.
Therefore, this paper bases adolescence on the World Health Organization (WHO) definition of
10-19 years10. The American Diabetes Association (ADA) recognizes that the management of
T1D in adolescents has unique considerations and should be thought of independently from other
age groups 6. This consideration is necessary because adolescents are experiencing biological
maturation through puberty, cognitive maturation through improvements in critical thinking and
reasoning skills, and becoming more independent, self-aware, and more attached to peer groups6.
This transition period is vulnerable to influences that impair the management of T1D because
glycemic control commonly deteriorates through adolescence, and patients appear to have
difficulties achieving glycemic control when transitioning from pediatric to adult care5,18. These
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findings imply that psychosocial factors partially influence the ability to achieve glycemic
control, and adolescents require additional care and support from their providers to accomplish
their treatment goals6,11,12.
Psychosocial factors are imperative to acknowledge and understand because of their
impact on the management of T1D6,11,12,13,15, 17. T1D is a systemic disease requiring daily and
intensive treatment. The constant intensity of T1D allows many elements to influence patients'
ability to maintain glycemic control through physiological changes, comorbidities, healthcare
access, and intersectional factors like socioeconomic status (SES), race, gender identity, and
sexual orientation11,12,13,15,19,22,23. The relationship between glycemic control and psychosocial
experiences is difficult to determine because it is complicated. However, increasing provider
understanding and awareness of these impacts can lead to improved glycemic control through
targeted interventions13,15,22,54. Moreover, it is not just the adolescent stage that impacts glycemic
control in patients with T1D; there are many social influences on morbidity and mortality in
patients with T1D. Across all age groups and socioeconomic strata of patients with T1D, nonWhite, female patients have a mortality rate approximately three times higher than their white
male counter parts14,16. Adolescents maintain this pattern, which makes psychosocial influences
imperative to study to fully understand how glycemic control is affected in this age group.
The recognition of health disparities and the influences of psychosocial factors on the
management of T1D through an integrative team approach leads to increased glycemic control
and decreased diabetic-related complications6,11,12,13,15, 17. This paper will explore the
psychosocial factors that impact blood glucose control of T1D in adolescents, the interventions
that most successfully address these elements, and recommendations to primary care providers
on how to address these issues through multidisciplinary care.
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Background: (Literature Review)
Adolescent Development and Behavioral Interventions
Adolescence is a period of biological, social, and psychological maturation. This unique
developmental stage is vulnerable to psychosocial influences that affect the morbidity and
mortality of adolescents with T1D diabetes. During this period of development, adolescents are
attempting to forge autonomy financially and socially, all while battling a chronic illness that
takes up a considerable amount of their time6. Considering the effects of psychosocial factors is
especially important in adolescents with T1D because it is a chronic disease requiring intensive
daily treatment. This population is navigating through quickly changing social, academic, and
professional landscapes and are evolving physically, mentally, and socially. These changes have
effects on the pathology of T1D forcing patients in this age group to reevaluate how to maintain
glycemic control6. For example, puberty causes an increase in insulin resistance and hormonal
changes that necessitates the adjustment of insulin dosages6. Refining treatments to account for
these changes also appears to be especially challenging in this population because adjustments to
insulin regimens have harmful side effects for adolescents6. The ADA has published protocols to
lower HbA1c levels that are specific to adolescents. These protocols are necessary because this
population has an increased risk for hypoglycemia due to physiologic changes unique to this age
group6. The mixture of biologic and psychosocial changes throughout adolescence makes
managing T1D in this population a delicate and unique process because of the impact these
factors have on blood glucose levels.
The most apparent change during the psychosocial development of adolescence is the
strive to develop autonomy from their parents and to learn skills that allow them to be
responsible for themselves. These patients are not only transitioning into adulthood physically
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but are also maturing mentally. Although learning to manage with less supervision is an essential
part of this stage, adolescents with T1D may need more support than has been historically
provided. Studies show that during the years of transition to adult care from pediatric care,
patients with T1D had an increased risk of poorer glycemic control showing HbA1c values 2.5%
higher than their counterparts that remained in pediatric care17. This deterioration of glycemic
control was independent of previous levels of control while in pediatric care, suggesting that it is
some aspect of the transition that is causing poorer control in this population18. The cause of the
barriers to transition is most likely multifactorial, including lack of standardization of transition
protocols for providers, perceived differences in care methods from adult and pediatric providers,
and patients feeling uncomfortable or unprepared to leave their pediatric endocrinologist18,19.
Developing a better understanding of why adolescents seem to struggle with this
transition is vital for improving T1D management and reducing future complications. Research
that implements behavioral management in adolescent T1D treatments may help answer this
question. Studies have shown that adolescents who experience higher self-efficacy and routinely
expect positive outcomes achieve improved glycemic control20. I
,

, and thoughts to reach set goals, known as self-

regulation, are correlated with improvements in T1D management20. These findings suggest that
behavioral interventions may be useful in this population19,20,21,22,23.
Research trials of behavioral management strategies studied the effects of these methods
on glycemic control in T1D. One strategy is known as Coping Skills Training (CST). It attempts
to improve self-management skills in stressful social situations and deter harmful coping
mechanisms through group workshop sessions20. Adolescents taught to use CST showed
improved glycemic control compared with individuals who did not use CST20. Although a more
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thorough understanding of these results is still required, research does indicate that this
population still requires emotional and physical support from caregivers to improve glycemic
control6,18,19,20,21,22.
Adolescence is a time that can cause shifts in family dynamics because of social and
developmental changes. It is common for caregivers to assume that adolescent patients can take
on managing most of their T1D on their own because this age group can independently
accomplish many treatment tasks and have a decent understanding of the disease6. However,
family involvement throughout adolescence appears to be important for glycemic control as
patients with T1D appear to meet treatment goals more often when they experienced greater
parental involvement and greater amounts of emotional and physical support6,20,22. A randomized
control study showed improvements in glycemic control when employing behavioral
interventions that focused on familial involvement compared to adolescents with T1D receiving
standard care20. The two interventions studied are referred to as "Family Teamwork" and
"Behavioral Family Systems Therapy" and resulted in improved glycemic control for two years
and 18 months, respectively, following each intervention20. Furthermore, family conflicts
intensify due to the added stress diabetes management has on caregivers, siblings, and
patients6,15,22. The incorporation of behavioral interventions with T1D treatment plans that
provided families with diabetes education, developmental education based on the age of the
patient, and training for familial communication and conflict prevention and resolution following
routine diabetic care appointments have been shown to improve glycemic control15,20.
Motivational interviewing (MI) is another behavioral intervention that attempts to help
patients decipher what intrinsically motivates their behaviors through collaborative
conversations23. A randomized control study from 2013 found that youths with T1D provided MI
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had a 2% decrease in HbA1c levels after three months of MI treatment25. MI implementation
decreased HbA1c levels more in patients who had higher HbA1c levels before treatment, and all
patients saw even greater improvements when caregivers were involved 25. Behavioral
interventions that decrease the impact psychosocial stressors have on human physiology appears
to improve glycemic control.
External stressors can have a substantial impact on glucose control because it is a
complicated systemic disease. In addition to familial stress, another example of an intense
stressor that adolescents experience is peer-related stress. The demands of SMBG, potentially
wearing a pump and having to be more conscious of food intake, make this disease visible to
people outside of the care team. Patients with T1D report issues with self-esteem, peer pressure,
feeling "different," and feeling judged by their peers when caring for their diabetes 25. In a
randomized control clinical trial that aimed to determine the types of stressors adolescents
experience, adolescents with T1D responded to interactive questions about "general life
stressors" and "diabetes-related stressors." Researchers evaluated these responses and found that
adolescents experienced "general life stressors related to their developmental age" most often,
but "diabetes-related stressors" were of higher magnitude and influenced their perceptions of
"not fitting in" with peers more than their "life stressors"25. These findings indicate that
adolescents with T1D experience more stressors than the general population in their age group
and that peer influences and perceptions may be a very impactful motivator to achieving
glycemic control in adolescents.
An increase in dependence on peer relationships and yearning for more independence is
common in adolescence6. This combination exposes individuals to scenarios that they have not
experienced before, such as driving and experimenting with drugs, tobacco, alcohol, and sex6.
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Navigating through these new experiences can be difficult psychosocially and can also affect the
management of T1D. The ADA recommends that the provider discuss these topics proactively
with their patients with T1D6. The intensity of peer influence is also a positive factor within this
population as peer-group interventions have shown to improve treatment adherence.
An example of this is the shared medical appointment model (SMA). SMA is a newer
strategy that aims to deliver patient education more effectively and enhance patient support
through peer interactions and provider feedback26. Patients with T1D attend appointments in
groups to ask questions and discuss issues that individuals have with provider input and
supervision. Although there is little research on how these appointments impact glycemic control
in adolescents with T1D, patients and providers have reported perceiving benefits such as
increased knowledge of the disease as well as increased support during lifestyle discussions26.
Effects of Comorbidities
Although biopsychosocial influences impact T1D in all stages of life, adolescents appear
to be particularly sensitive to the factors which affect their ability to properly manage diabetes by
performing physical tasks such as SMBG and intricate cognitive tasks such as determining
insulin dosages and how to remedy abnormal blood glucose levels. Patients with T1D experience
comorbid conditions, including endocrine diseases, metabolic disorders, and psychological
disorders at a much higher rate than the general population6. Studies have shown that if an
individual is diagnosed with T1D in early adolescence, they are at increased risk for mental
health disorders26. According to the ADA, adolescents with T1D are three times as likely to have
a psychiatric disorder like major depressive disorder or anxiety than their peers. These patients
also have a 30% chance of being diagnosed with a psychiatric disorder within 15-20 years of
T1D diagnosis6,27. Psychiatric disorders are worrisome in adolescents because this age group
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commonly struggles with glycemic control, and a decline in mental health can impair cognitive
and physical abilities, further inhibiting the management of T1D27.
The effects of T1D are systemic and fluctuate continuously throughout the day, allowing
additional pathologies to influence its management severely. T1D may even contribute to the
etiology of some disorders like psychiatric disorders27,28. Several studies have indicated a
correlation between psychiatric disorders and T1D, although there is no consensus of the origins
of this relationship27,28. A retrospective cohort study from 2018 shows that patients who had
elevated levels of HbA1c (>8.5%) within the first two years of T1D diagnosis were more likely
to be diagnosed with a subsequent psychiatric disorder such as depression or anxiety 27. The same
study concluded that 46% of 1,035 patients with T1D were diagnosed with two or more
psychiatric disorders, and 22.8% were diagnosed with three or more psychiatric disorders, which
are higher rates than the general population experiences 27. Additionally, suicidal ideation is also
found in much higher rates in adolescents recently diagnosed with diabetes than the general
population, with 26.4% reporting thoughts of suicide. However, suicide attempt rates of
adolescents with T1D reflects similar percentages of the general population 6.
Although the cause of psychiatric disorder development in T1D is unknown, research has
found a correlation between glycemic control and mental health disorders. Poor glycemic control
correlates with increased risk of developing a psychiatric disorder, and the ability to maintain
glycemic control decreases when patients are diagnosed with a comorbid mental illness 27. A
retrospective cohort study in 2018 found that patients who had a preexisting mental health
disorder when they were diagnosed with T1D were more likely to have elevated HbA1c levels
during the first two years of management compared to patients without a preexisting psychiatric
disorder27. Depression is also positively correlated with increased rates of DKA in adolescents 6.
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The other common mood disorder diagnosed in patients with T1D is generalized anxiety
disorder (GAD). Anxiety poses a unique threat to T1D because its symptoms may mimic
hypoglycemic episodes, furthering hypoglycemic anxiety, and complicating patients' ability to
discern when they are having a hypoglycemic episode28. Anxiety surrounding the fear of needles
is also a debilitating factor for patients newly diagnosed with diabetes and negatively affects
glycemic control39. Implementing a multidisciplinary team specializing in T1D management has
shown to improve glycemic control, mental health conditions, and health care costs28.
In addition to mood disorders, eating disorders are of great concern for providers caring
for patients with T1D because of the increased morbidity and mortality they can cause in this
population. For example, patients with T1D who suffer from anorexia are sixteen times more
likely to die than their non-diabetic counterparts6. Patients with T1D who are classified as
females are twice as likely to develop an eating disorder than the general population28. However,
the research may be biased to focus on eating disorders in females with T1D 28. According to the
ADA, 31-40% of women ages 15-30 with T1D report disordered eating patterns such as bingeeating, and insulin restriction28. In light of this, the ADA recommends screening for eating
disorders when patients experience recurrent DKA episodes or refractory poor glycemic
control6. Whether there is a difference between the prevalence of eating disorders within
adolescent diabetic populations versus the general public is still being debated. However,
patients with diabetes are at risk for an eating disorder unique to patients with diabetes, referred
to as "insulin omission"6. Adolescent females have higher rates of developing this disorder and
had worsened glycemic control, microvascular complications, and hospitalizations28. Whether
eating disorders are more prevalent in patients with diabetes than in the general population, all
disordered eating inhibits glycemic control, increased rates of hospitalizations, and diabetic-
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related complications such as retinopathy, neuropathy, and premature death28. Because the rates
of mood disorders, eating disorders, and psychiatric disorders in patients with diabetes are high
in adolescents, recognizing, appropriately treating and preventing the progression of these
conditions will improve T1D management and help prevent future diabetic-related
complications.
Another example of psychiatric diseases specific to T1D is Diabetic-related Distress
(DRD). DRD is seen in 41% of patients with T1D and is defined as distress related to the selfmanagement of diabetes, including perceptions of support, access to quality health care, and the
emotional toll management of chronic disease and requires different treatment strategies than
other mental health disorders29. Distinguishing this disorder from other psychiatric disorders is
essential because DRD is unique to patients who must adhere to diabetes management, is more
often chronic, and is
disorders such as depression and anxiety29. For example, based on a randomized control trial
concluded that "emotion-focused" and "educational/behavioral" interventions in patients with
elevated D.D. and HbA1c levels significantly improved the psychologic symptoms and increased
glycemic control as compared to those without these treatments29. Because the improvements in
HbA1c levels were modest compared to the decrease in D.D. symptoms, researchers suggested
that continuous screening and implementation of behavioral management may improve HbA1c
levels by preventing DD29. Patients with T1D have unique considerations when it comes to
psychiatric disorders and may require multidisciplinary care to recognize, prevent, and treat these
conditions.
Impact of Intellectual Disabilities

Glycemic Control in Adolescents with T1D, 15
Another population that requires special considerations and a collaborative model
approach are individuals with intellectual disabilities (I.D.). Research suggests that populations
that suffer from I.D. are at a heightened risk of developing T1D due to effects from
developmental syndromes30. For example, patients who have Down Syndrome are at the highest
risk of developing T1D compared to other intellectual disabilities30. This patient population is of
particular concern because impairments in neurodevelopment are associated with deficiencies in
executive functioning and may lead to worsened glycemic control outcomes because of poor
adherence to treatments27. These patients were also more likely to have comorbidities such as
hypertension and hyperlipidemia and worsen glycemic control than their non-disabled, T1D
counterparts30. Obesity and a propensity for a more sedentary lifestyle have been associated with
individuals with I.D. and are known to aggravate diabetic-related complications39. Healthcare
access is limited among this population leading to worsened preventative healthcare, medical
education, and treatment outcomes30.
Compromised communication between the healthcare and the patient may be a portion of
the problem as many people with I.D. communicate differently than the general population and
may require extra, focused patient education strategies30. Evidence of ineffective communication
is apparent when examining rates of routine screening tests for T1D within this population.
People with diabetes with I.D. who were 16 years and older were likely to miss their yearly
diabetic appointments, and even when they saw a provider, they were still less likely to receive
the same screening evaluations as the general population30. A 2018 study in Canada showed that
94% of patients with T1D and I.D. saw their primary care provider, but only 52% received blood
glucose checks, 44% underwent lipid evaluation, 29% were screened for retinopathy, and only
19% were evaluated for microalbuminuria30. Screening for diabetic-related complications and
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additional comorbidities is a routine part of check-ups for patients with T1D and is especially
crucial in patients with I.D. because they are at higher risk for developing comorbidities than the
general population.
In addition to the lack of routine screening, patients in this population have also
demonstrated poor glycemic control in several studies. A U.K. cohort study of 125 individuals
found that 50% of patients with I.D. and T1D did not meet HA1c goals even when they were in
contact with their providers30. With uncontrolled glycemic levels, an individual is at risk for
experiencing symptoms related to hyperglycemia and hypoglycemia, which can both be medical
emergencies. Patients with I.D. are more likely to have undiagnosed medical conditions,
including these acute complications of T1D due to a phenomenon called "diagnostic
overshadowing"30. Providers tend to attribute the symptoms an individual is experiencing to their
diagnosis of I.D. instead of diabetic-related complications30. This false attribution puts these
patients at a higher risk of not receiving adequate emergent medical attention. Although studies
have not explicitly evaluated how I.D. affects T1D management in the adolescent population, the
studies show deteriorating glycemic control starting at age 16, which suggests that this
population may also have difficulty transitioning from pediatric to adult care with the added
barriers related to their I.D. diagnoses. This research also highlights the importance of screening
in this population because poor control can be related to comorbid-related influences, and these
patients are at risk for suffering from undiagnosed disorders.
Intersectional Effects on Healthcare Access
Socioeconomic Status, Healthcare Costs and Health Insurance
The inability to access quality healthcare appears to affect specific populations
disproportionally and leads to difficulties managing chronic conditions such as T1D 8,11,12,13,22.
The inability to access healthcare is attributed to structural barriers within the healthcare system
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and affects metabolic control in T1D. Patients of lower SES have worse glycemic control and
have higher rates of complications from T1D8. Individuals on public insurance and from singleparent households are also more likely to have poor glycemic control8,21. Adolescents of lower
SES may experience poorer glycemic control due to a lack of resources, decreased ability for
caregivers to provide supervision of T1D management, and an increase in social stressors than
those of higher SES8.
The connection between glycemic control and SES is multifactorial with physiological
and social roots. A study by Zilioli et al. attempted to determine the cause of this phenomenon by
examining the relationship between life stressors, diabetes-related stress, and glycemic control.
Researches collected demographic data through questionnaires from 66 participants aged 16-20
years and measured diurnal cortisol levels from saliva samples taken four times a day for two
weekdays and two weekend days8. The study found that lower SES was associated with higher
levels of stress, and researchers hypothesized that class discrimination and insufficient resources
were responsible for this relationship8. This research team hypothesized that these psychological
stressors might impact patients with T1D by disrupting the hypothalamic-pituitary-axis, which
assists in regulating blood glucose levels and causes an increase in cortisol levels 8. Increased
cortisol levels result in increased gluconeogenesis, inhibition of insulin sensitivity, and decreased
uptake of glucose in the periphery8. This study confirmed that individuals of lower SES who
reported more stressors had patterns of cortisol release associated with higher levels of HbA1c 8.
These studies imply that patients' ability to feel secure in accessing their medical supplies and
treatment needs impacts the care of T1D.
Although medical needs for T1D is individualized to each patient, every patient requires
insulin to survive. Patients with T1D also have additional provider visits, hospitalizations, and
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more medical supplies than the average adolescent. Those services require patients with T1D to
pay more for healthcare than the general public, but the price of insulin alone may be the most
significant financial burden on patients with T1D31. Multiple studies show that this healthcare
cost affects T1D management. For example, a study published in 2020 concluded that insulin
accounted for 18% of all out-of-pocket medical spending in patients with T1D on private
insurance31.
Additionally, patients of lower SES were less likely to be on insulin pump therapies, and
if patients that felt as though they were paying high costs for test strips, they were less likely to
perform SBGM sufficiently. Both of those interventions are known to improve glycemic control
in T1D21. Insecurities about costs can lead patients to apply unhealthy coping strategies. A
survey from 2019 determined that 25% of individuals who visited an outpatient diabetes center
in Connecticut reported underuse of their insulin due to cost. Of these patients, 37% of them did
not discuss this issue with their providers32. The cost of lifesaving measures for T1D has caused
such a burden on adolescents that there are multiple incidences of fatalities caused by patients
purposely giving themselves lower doses or fasting to save more insulin32,33. Insecurities in
medical payments not only affect long-term management of T1D but also can cause severe acute
complications and appear to be an issue that patients do not eagerly bring up with their providers.
Health insurance coverage is another uncertainty that patients with T1D in the U.S.
experience disproportionately to the general population. The insecurity of healthcare insurance
coverage is a massive burden because the cost of T1D is expensive due to medical supplies, the
cost of insulin, and provider appointments. For example, the CDC estimates that adolescents
with T1D pay an average of $9,333/year for medical costs than $1,468/y without T1D 34. These
uncertainties related to healthcare coverage can be an intense stressor for patients. A cross-
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sectional study examined data from national population-based surveys from 1999-2006 and
found that glycemic control improved with better health insurance coverage11. A more recent
cross-sectional study in 2018 determined through analyzing data from surveys from 2010-2016
that although healthcare insurance coverage has improved for all ages since the Affordable Care
Act was implemented, adolescents, as well as young adults, are still at a higher risk than other
age groups to be uninsured35. The issue of adolescent coverage was also independently addressed
in the ACA, allowing patients to remain on their parent's health insurance until they are 26 years
old34. According to this research, insurance coverage is a known threat to receiving adequate
healthcare in adolescence, impacting treatment outcomes for T1D.
Structural Barriers
Further social elements such as race, ethnicity, gender identity, and sexual orientation are
related to healthcare access and healthcare outcomes 12,13,17, 21,36,37. A
explains why cultural and ethnic minorities experience poorer health than the
majority population36. Minority populations experience discrimination and maltreatment daily,
which triggers the sympathetic nervous system to deal with the stress 36. When experienced daily,
this heightened physiological response is hypothesized to be a risk factor for many chronic
diseases as it has negative systemic effects36. The majority of physicians and advanced practice
providers identify as non-Hispanic White37,38. This homogeneity lends itself to innate cultural
and ethnic biases that the provider carries into their practice. This unconscious bias of the
provider, coupled with the systemic racism that permeates the healthcare system in the U.S.
creates a challenging environment for patients who identify out of this majority.
As the U.S. continues to struggle with racism, a continuous influx of studies shows that
the healthcare system is not immune to its effects. In addition to subconscious bias, race-based
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research data, and systemic racism within the healthcare system, individuals who are Black,
Indigenous, or People of Color (BIPOC) are more likely to face financial struggles, poorer health
outcomes and have less access to healthcare in general21,39. Moreover, a cross-sectional analysis
in 2013 evaluated medical data from patients with T1D between 13-20 years old and found that
only 14% of Black patients met ADA HbA1c goals compared to 28% of Hispanic patients 34%
of non-Hispanic White patients even when researchers controlled for SES factors17. BIPOC are
also less likely to use diabetic technology, which can improve glycemic control. This technology
includes continuous glucose monitors (CGM), insulin pumps, and closed-loop monitoring
devices. Additionally, BIPOC are less likely to have intensive insulin therapies and adequate
amounts of SMBG checks per day21,39. For example, in a 2015 cross-sectional analysis of
patients younger than 18 years old, insulin pumps were used by 61% of non-Hispanic White
patients, 26% of Black patients, and 39% of Hispanic patients39.
This same study discovered that disparities are particularly striking when comparing
glycemic control in Black and White adolescent populations. Black patients with T1D younger
than 25 years of age were found to have increased rates of diabetic ketoacidosis leading to a
mortality nine times higher than that of non-Hispanic White patients39. Black children of the
highest SES had poorer glycemic control (HbA1c of 9.6%) than white children of lower SES
(HbA1c of 8.4%)39. The fact this disparity occurs across all SES levels appears to be unique to
Black patients with T1D because once researchers accounted for SES, there were no differences
in glycemic control between non-Hispanic White patients and Hispanic patients39. According to
a recent publication from the ADA, inequalities in healthcare lead to more diabetic-related
complications in the Black population14. Black patients experience retinopathy at 46% higher
rates than in non-Hispanic White patients14. They also suffered increased rates of nephropathy
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that required dialysis and limb amputations14. These studies show that glycemic control is related
to ethnicity and race, which puts racial minorities, especially Black patients, at an increased risk
for future diabetic-related complications and worsened quality of life39,14. These studies indicate
that Black patients have added impairments to achieving glycemic control than other racial
minorities and White patients with T1D.
The U.S. is comprised of a wide variety of ethnicities and cultures. Cultural perspectives
affect how patients perceive their healthcare, adhere to their medical treatments, and receive their
patient education. A common barrier for ethnic minorities in the U.S. healthcare system is
language. According to the U.S. Census Bureau, 18% of the U.S. population spoke a language
other than English, and 11.9 million households did not speak proficient English40. The U.S.
Census Bureau expects that the number of people who speak languages other than English will
continue rising, making it a critical psychosocial-related barrier to healthcare considerations40.
For example, one study found that patients who did not speak English were less likely to perform
self-monitoring blood glucose checks adequately41. Another study showed that providing a
Spanish-speaking clinic for adolescents with T1D who spoke Spanish as their first language
improved their glycemic control41. This finding suggests that cultural differences have important
implications for the management of T1D and healthcare access overall.
T1D influences most aspects of everyday life for patients. They must continuously
monitor this disease while eating and being physically active. Nutrition appears to be an
additional factor that creates inequality for patients with T1D because of limited access to a
variety of nutritious foods, referred to as "food insecurity." Individuals may experience food
insecurity because they live in an area that is physically far from stable sources of nutrition,
known as "food deserts," or the inability to afford quality foods. Adolescents with T1D have
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higher rates of food insecurity than the national population42. The majority of people within
,

SES, and because of racial and ethnic disparities between SES classes,

this issue disproportionately affects BIPOC and single women42. Having inadequate access to
proper nutrition leads to unacceptable coping strategies such as skipping meals and consuming
large portions of processed foods with a long shelf life but are low in nutritional value42. Factors
like these may help explain the positive correlation between food insecurity rates and obesity
rates42.
Overall, the rate of obesity in adolescent populations has been increasing dramatically
since the 1980s and has detrimental effects on T1D management and future complications 22.
People with T1D who also suffer from obesity are at increased risk for microvascular and
macrovascular complications than the general population. Patients who experience food
insecurity appear to be at especially high risk for these complications. A Canadian study from
2014 concluded that even when researchers controlled for social, demographic and diseaserelated factors, food-insecure patients with T1D were at risk for having HbA1c levels higher than
7% and experienced more hypoglycemic episodes, emergency department visits and higher rates
of comorbidities such as hypertension, hyperlipidemia, mood disorders, and tobacco use43.
Employing a team-based approach that allows for a diabetic educator to provide nutritional
education for diabetes management and a social service specialist that can help minimize food
insecurities may improvements in HbA1c levels6.
Cultural Influences
Comparing glycemic control in two ethnic and cultural minorities in the U.S. exemplifies
the effect cultural differences have on healthcare outcomes. A cross-sectional analysis of
adolescent patients with T1D in 2016 found that 50% of patients from Latinx and Asian descent
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did not meet their glycemic control goals22. These outcomes were due to a combination of
English proficiency, healthcare access, SES, family dynamics, comorbidities, and acculturation
(defined as the number of generations born in the U.S.)21,22. For example, Hispanic and Black
populations have higher rates of obesity in youths diagnosed with T1D than other ethnicities 22.
Culture also influences how family involvement influences glycemic control. For example, a
literature review from 2016 found that Latinx families that more recently immigrated to the U.S.
reported higher degrees of family support and, therefore, better treatment adherence and
improved glycemic control22. In this same study, Latinx populations with more generations born
with the U.S. had higher rates of depression, while less acculturated Asian populations
experienced higher rates of mental health problems22. This research implies that increasing
attention to differences in cultures within healthcare systems and shaping diabetic education and
care to differences in cultures may decrease diabetic-related complications for adolescents.
In addition to race and ethnicity, gender identity, and sexual orientation of an individual
is related to healthcare access and outcomes36. LGBTQ+ patients are more likely to avoid
healthcare and delay seeking medical attention due to perceptions of discriminatory and unequal
treatment from healthcare providers. This population is also twice as likely to be uninsured than
their cisgender, heterosexual counterparts36. Adolescents in this population face considerable
amounts of disparities while moving throughout the world, including increased risk of physical,
emotional, and sexual abuse and increased rates of homelessness 42. They also experience higher
rates of mood disorders, substance abuse, and suicidal ideation than the general population44.
LGBTQ+ adolescents that suffer from T1D are not only constantly aware of their
physical and emotional safety because of societal inequalities, but also must consistently
maintain adequate glycemic control to function. Comparing the management of T1D in
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LGBTQ+ populations with the general public is difficult to do as LGBTQ+ status is often
underreported or incorrectly collected45. Additionally, information and research on T1D
management within these populations is lacking. A cohort study conducted in Belgium in 2017
examined the rates of T1D in transgender populations by analyzing medical records of 1,081
transgender patients and found that T1D was 2.3 times higher within this population than the
general population46. Defreyene et al. suggest that this relationship may be caused by the
additional psychosocial stressors that transgender individuals experience, including stigma,
emotional disorders, and the biopsychosocial stresses of electing to undergo gender-affirming
hormone therapy46. Researchers need to conduct more extensive, diverse studies to decipher the
relationship between gender identity and T1D. However, the added daily psychosocial stress that
transgender patients experience indicates that this population requires additional support when
managing T1D.
Accessibility of Diabetic Specialists
The accessibility of providers that specialize in T1D care has been shown to improve
outcomes for patients47. Unfortunately, the number of patients diagnosed with T1D is increasing
while the number of endocrinologists is decreasing47. According to the Endocrine Society, there
has been a national shortage of endocrinologists that is continuing to worsen due to longer
patient life expectancies, increasing prevalence of endocrine disorders, and insufficient numbers
of physicians specializing in endocrine47. This trend was noticed in 2000 and has appeared to
worsen over time47,48. In 2008 pediatric patients with T1D outnumbered endocrinologists 300:1.
An Endocrinologist Survey in 2012 showed that this shortage continued, determining that the
average wait for an appointment with an endocrinologist in the U.S. was 37 days 47,76. Although
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this affects all populations, it is exacerbated based on geographic location as some patients
depending on the region they lived experienced appointment waitlists of 3-6 months48.
Approximately 50% of pediatric endocrinologists work in academic centers within
metropolitan areas, which indicates that in addition to being physically distant, patients in
medically underserved areas may experience longer waitlists to get an appointment, and
providers may have less time per patient47. A cross-sectional analysis of patient data from 2015
showed that patients who lived within 50-miles from a pediatric endocrinologist were less likely
to access these services than patients who lived 20 miles from specialized medical centers48.
Furthermore, urban areas that were 50-miles away from these specialty centers had even less
access to pediatric endocrinologists due to higher patient to physician ratios than rural areas 48.
These studies show that barriers to healthcare access include limited access to public
transportation and longer travel times. Strategies to mitigate these barriers are essential to
improving T1D management in adolescents because studies show that frequent communication
with diabetes care teams improves patient outcomes with reduced acute and chronic
complications and decreased healthcare costs6.
Methods:
This paper used a database search of Pubmed, National Center for Biotechnology
Information, and Google Scholar. The keywords used during this search were "psychosocial
effects on glycemic control of adolescents," "psychosocial effects on glycemic control,"
"glycemic control in type 1 diabetics", "psychosocial effects, glycemic control," "psychosocial,
glycemic control," "psychologic disorders, T1D". A filter was set on these searches to include
articles published from the years 1999-2020. Further articles were selected from the references
used in articles found from the initial search. Articles selected focused on patients with T1D
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between the ages of 10-19 years old, which was selected to define "adolescent" based on the
definition from the WHO10. Articles were excluded from selection if unavailable in English
translations. A Registered Dietician specialist in diabetes education, Carol Brunzell RD, L.D.,
CDE, from the University of Minnesota, was interviewed via e-mail about her experience with
adolescents with T1D within her practice.
Discussion:
For reasons yet to be discovered, the rising global incidence of T1D disproportionately
impacts adolescents1,2,3. In addition to the rising number of patients with T1D, this age group has
shown a consistent pattern of deteriorating glycemic control6,8,12,15,19,22. This combination has the
potential to negatively impact patients with T1D, their support systems, and society as a whole
due to increased diabetic-related complications and their resultant healthcare costs. Many studies
identify adolescence as a vulnerable developmental period for patients with T1D. Much of the
literature focuses on discovering which biopsychosocial factors contribute to the difficulty
maintaining glycemic control and to what degree, but few studies attempt to discover solutions to
these influences 5,6,11,12,15,19,22. Practitioners are encouraged to recognize that poor glycemic
control in adolescence is likely due to an amalgamation of elements. Therefore, treatment is
often encouraged to include a multidisciplinary approach with individualized treatment plans
tailored to the patient's risk factors for complications, presence of comorbidities, and
comfortability with self-management skills6. Developing advancements that help adolescents
maintain glycemic control will decrease diabetic-related complications in future older adult
populations, lessen healthcare costs, and increase the quality of life for millions of people
impacted by this disease5,6,11,12,15,19,22. Increasing access to quality healthcare, prescribing
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diabetic technology, and implementing behavioral interventions have been shown to improve
glycemic control in adolescents5,6,11,12,15,19,22.
Improving access to healthcare is an overarching subject that encompasses many aspects
of control in T1D. Access to quality healthcare not only includes the ability for patients to
physically interact with healthcare teams but also includes the ability to financial access services
and receive necessary preventative, therapeutic, and palliative care. Psychosocial barriers can
inhibit access to healthcare, such as screening work-ups, comprehensive patient education, a
multidisciplinary diabetic care team, and diabetic technologies, all of which improve glycemic
control5,6,11,12,15,19,22. Difficulty to access healthcare is influenced by psychosocial factors,
including socioeconomic status, geographic location, race, ethnicity, gender identity, sexuality,
and comorbidities5,6,11,12,15,19,22. Screening and evaluating for psychosocial impairments routinely
in patients with T1D appear to be influential in preventing diabetic-related complications
because of the powerful impact these factors can have on glycemic control6,11,13,15,17. Although
healthcare providers should improve access to quality healthcare for their patients and decrease
psychosocial influences on glycemic control, many systemic barriers exist above the level of
provider control.
Healthcare reform policies through all healthcare levels are vital to improve care for
patients with T1D and decrease racial, economic, and cultural disparities in the management of
the disease. For example, studies have shown that the Affordable Care Act (ACA) has begun
decreasing inequality in healthcare by expanding coverage for populations historically
uninsured48. The populations that most benefited from the ACA were BIPOC, youth, and those
of lower SES. These are the same populations that are most likely to experience diabetic-related
complications25,47. Adolescents benefited from certain aspects of this policy as individuals could
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remain insured by their caregivers until age 26. This change in policy indicates that the transition
from pediatric to adult care may be universally difficult for all adolescents and is not unique to
diabetic patients further supports the theory that adolescence is a vulnerable developmental
period requiring more healthcare support than has been historically given to this
population6,18,19,25,49. Despite these improvements, racial, gender, socioeconomic, and cultural
disparities in healthcare access of adolescents remain and require improvements in systemic
changes such as Medicaid expansion49.
A strategy that can mitigate systemic influences on glycemic control is to implement an
integrated diabetic care team that includes team members who have in-depth knowledge of T1D
and specialize in different aspects of its management 13,20,21,23. This approach increases the quality
of diabetic education, which can improve healthcare access by giving patients the tools to
advocate for themselves. These tools include increased knowledge of T1D, its treatment, and
how to navigate the healthcare system and social services. The diagnosis of T1D drastically
alters an individual's life and is a considerable burden for adolescents already experiencing so
many life changes. This unique developmental period requires continuous amounts of support
and education from the diabetic care team. Integrative healthcare is especially important in
populations that require more time and resources to provide adequate care, such as patients with
additional comorbidities or intellectual disabilities27,28,30. For example, diabetic educators are
essential because they increase the amount of time spent on educating patients on the minutiae of
particular topics including diet, exercise and lifestyle choices as well as providing assistance with
screening for comorbidities such as mental health disorders (Personal communication, Carol
Brunzel, May 30, 2020). Increasing patient education in diabetic populations will allow them to
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not only be able to improve their management of T1D but allow them to become better selfadvocates for their care.
The use of a multidisciplinary, educational approach can improve healthcare disparities
by providing focused, individualized care based on each patient's psychosocial needs. Nutrition
and exercise are topics especially pertinent to managing T1D and requires a lot of education and
guidance. Proper nutrition is an aspect that unites socioeconomic status, ethnicity, race, gender,
and culture. Because food insecurity unequally impacts adolescents with T1D, females and
ethnic minorities, improving nutritional education and providing interventions for patients to
have access to quality nutrition could help decrease these discrepancies42. Obesity and sedentary
lifestyles also have psychosocial-based patterns with higher rates in individuals with I.D. and
ethnic minorities22. Regular exercise is imperative for adequate glucose control in patients with
T1D. The same benefits of exercise seen in adult populations apply to adolescent populations,
including decreased adipose tissue and improvements in mental and cardiovascular health 6.
Although cardiovascular fitness may not directly improve HbA1c levels, it may decrease the risk
of other comorbidities that impair T1D management6. Despite the value of exercise in patients
with T1D, there are still risks associated with exercise, such as fluctuations in blood glucose
levels6. Because patients with T1D have unique considerations when it comes to exercising, it
requires extra planning from the caregivers to ensure that complications such as hypoglycemia
do not occur. Caregivers must also educate the patient and the authority figure involved in the
activity to understand how to manage T1D and avoid acute complications6. Understanding how
diet and exercise affect glycemic control in T1D is essential for obtaining adequate control of
blood glucose levels and is improved when patients receive intensive, integrated diabeticeducation6(Personal communication, Carol Brunzel, May 30, 2020).
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This team-based approach can also address factors unique to adolescent development that
can negatively impact glycemic control. Adolescents are exposed to many changes through peer
interaction and self-discovery during this developmental period that can influence glycemic
control. The ADA recommends that providers speak with patients with T1D individually starting
at age 12 to proactively discuss how new experiences that are common in this age group can
affect the management of T1D as well as provide an accepting, open environment for questions
and concerns6. Discovering one's sexuality and gender identity is an essential component of
adolescent development38. Providers should routinely discuss safe sex practices, reproductive
health, and provide contraceptive options6. Due to the disparities seen between LGBTQ+
population and cisgender heterosexual counterparts related to diabetic complications, providers
should do what they can to reduce heteronormative and sexuality-based discrimination within
their facilities38. Providers could encourage training on cultural sensitivity to help lessen the
LGBTQ+ population's stressors and encourage regular communication with the diabetes care
team38. Providers should be aware that this population may need more support in reducing
psychosocial stressors that can worsen glycemic control, as seen in the minority stress model 38.
These aspects distinctive to adolescence require that medical management of this age group be
considered independently from other ages, and T1D treatments should fit their specific needs. A
team-based approach to the treatment of T1D would allow diabetic teams to more
comprehensively screen patients for concerns related to nutrition, exercise, lifestyle, and increase
education on these influential factors.
Developing practices specific to improving care in adolescents is especially important
when patients are transitioning to adult care because many patients experience deterioration of
glycemic control during this period. Patients tend to leave pediatric care towards the very end of
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adolescence between 18-21 years of age18. Studies have shown benefit when pediatric providers
implement strategies to improve the transition period at least one year prior to the transfer6,18,19.
These strategies involve a team-based approach with open communication and shared decision
making between the adult provider, pediatric diabetes care team, family, and the patient6. In
addition to patient education, a
training experienced shorter transition periods, sufficient transfer of patient records, and reduced
return of patients to pediatric care18. Despite this, providers who manage T1D report insufficient
guidance and protocols to follow during these transfers18. Providers state that the two most
common reasons for transferring patients are due to their continuous poor glycemic control and
are older than 18 years old. However, neither of these reasons fit the recommended criteria for
transferring pediatric patients according to the ADA, despite the logistics of transferring patients,
providers reported that their primary barrier to transferring pediatric patients to adult care was
that the patient felt an emotional attachment to the provider19. The struggle to maintain glycemic
control during the transition to adult care and the fact these patients admit patient-provider
relationships play an influential, emotional role during this stage further indicates how impactful
relationships can be in adolescent populations.
The fact that relationships influence adolescents strongly indicates that behavioral
interventions may be a beneficial addition to T1D management because they rely on
communication, vulnerability, and trust with the provider and group members. Behavioral
interventions involve a provider-patient relationship and sometimes use peer-peer relationships
to improve self-management skills, develop healthy coping methods, and help manage
psychosocial stressors that adolescents experience20,21. Behavioral interventions such as
motivational interviewing improve self-management skills, which are important aspects of T1D
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treatment. Self-management of T1D requires that patients regularly perform diabetes-related care
such as SMBG, adherence to insulin regimens, and awareness of the impacts of food intake and
activities21,23. Researchers argue that because the success of MI is rooted in the patient's internal
motivation, it may be particularly useful during shifts in development as in adolescence23. The
effects of MI were improved even more when family members and caregivers were a part of the
conversations. The importance of familial support in T1D is further supported by the fact that
behavioral family systems therapy decreased family conflict and increased familial involvement
in the management of T1D23. Strategies such as these may also help decrease disparities seen in
cultural minorities such as Latinx and Asian populations because familial influences impact T1D
management22. Although there is not enough conclusive evidence that behavioral interventions
have a direct effect on glycemic control, they appear to be promising additions to T1D treatment
in adolescent patients because they allow providers to target aspects specific to this
developmental period that increase glycemic control.
Diabetic technology is a recent addition to diabetic care that has improved the
management of T1D in adolescents. Increasing availability, decreasing cost, and access to
diabetic technology may improve all aspects of diabetes management, including increasing
healthcare access, diabetes education, decreasing healthcare disparities, and overall increasing
glycemic control16,50,52. This population is typically familiar with how the technology operates,
and many adolescents rely on its usage for many other aspects of life, which implies that
implementing it for T1D management may be a natural and helpful addition to these patients52.
Recently, Web-based platforms have delivered training and guidance to managing T1D51.
These platforms teach skills, such as coping mechanisms and problem-solving. Additionally,
social media platforms have allowed adolescents to communicate with peers who also suffer
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from T1D easily51. Although these platforms did not affect glycemic control, they were shown to
improve self-management behaviors and may reduce negative psychosocial influences on T1D
management. Less negative psychosocial influences have been correlated with fewer diabeticrelated complications in the future51. Technology has also been helpful in this population by
developing things, including text-message services and applications that send reminders for selfmanagement tasks, diabetes education, and even text messages of encouragement51. Studies have
also indicated that specific applications could support safe alcohol consumption in patients with
T1D. Although researchers are continuing to evalute if technological interventions can improve
glycemic control, adolescents report enjoying using these services, which indicates that this
technology could be a beneficial addition to T1D management51.
In addition to promoting self-management of T1D, developing technology for T1D has
also eased burdens of daily management tasks. Devices that can provide patients with continuous
glucose monitoring increase the amount of blood glucose checks per day and glycemic control
improves with increased SMBG checks51. CGM usage has been shown to reduce the number of
hypoglycemic episodes and DKA and improves HbA1c levels51. Enhancements in insulin
delivery devices have improved quality of life and glycemic control by administering insulin
through titratable, continuous subcutaneous infusion therapy, and meal boluses instead of
multiple daily injections of insulin51. A subsequent advancement is the combination of these
therapies by using sensor-augmented pumps or closed-loop systems that have also shown
improvements in T1D management51. This technology has allowed researchers to compile large
amounts of data that can be analyzed and evaluated to determine how to provide personalized
treatment plans16. Studies have shown that the use of these devices improves not only glycemic
control but also psychosocial burdens in adolescence 50. The use of data analytics has been shown
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to deliver higher-quality, individualized care to patients with T1D and may be especially helpful
for adolescents who are experiencing changes to their treatment regimens. However, as of 2015,
most patients between the ages of 2-25 years were not using these devices51. Although these
technologies require additional education and are more expensive for patients than injecting
insulin, they have been shown to improve glycemic control in T1D and could be a solution for
populations that struggle with T1D management16,50,51.
Additionally, racial and ethnic disparities provide barriers to accessing diabetic
technology as Black patients are the least likely population to be prescribed and use CGM,
insulin pumps, or closed-loop systems39. Increasing availability and accessibility to this
technology could improve T1D management for adolescents and decrease racial disparities in
health outcomes16,50,51. Studies have shown that racial and ethnic minorities experience worse
diabetic complications and perform fewer SMBG checks per day than their non-Hispanic White
counterparts46. These differences may improve with providers encouraging the usage of closeloops systems, CGMs, and insulin-pumps50,51.
Technology has improved self-care abilities in patients and has increased their ability to
access diabetic care teams. Telemedicine is a growing field and is effective in delivering
healthcare to medically underserved populations and delivering comparable quality to in-person
visits. Adolescents, in particular, have reported high levels of satisfaction from telehealth visits
in one study51. Meeting with a provider in a telehealth format decreases travel time and wait
time, which leaves both providers and patients with more time51,52. Patients from rural areas also
reported missing less school and work when using telehealth51,52. Telehealth may also help to
close the disparities in T1D management seen between socioeconomic classes. In a randomized
control trial in 2015, the use of telehealth appointments for T1D was evaluated in patients under
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18 years old and concluded that telehealth appointments lessen healthcare-related costs, increase
the number of times a patient visited and was as effective as in-person for maintaining HbA1c
levels51.
Telehealth has also increased the availability of diabetic specialists to areas that would
have otherwise gone without those services. Projects like Project Extension for Community
Health Outcomes (ECHO) train primary care providers to deliver specialized healthcare to areas
underserved by endocrinologists through telehealth services51. In addition to telehealth, closedloop systems may help make up for the decreasing number of endocrinologists because analytic
data software, as well as the ability to titrate dosages easily, allows providers to more efficiently
tailor needs to their patients47. This improvement ultimately leaves providers with more time,
which allows them to visit with more patients48. The programmability of closed-loop systems can
also allow patients to send glycemic levels to providers electronically, limiting the amount of inperson appointments patients need and increasing healthcare access to patients who have
difficulty traveling to the office.
Diabetic technology also has implications for reducing additional psychosocial barriers to
adequate glycemic control by reducing the impact of comorbidities 47,50. The high prevalence of
comorbidities in this population requires providers to be aware of the screening guidelines and
evidence-based screening tools. Providers should routinely screen adolescents with T1D for
metabolic disorders, including hypertension and hyperlipidemia, other endocrine disorders such
as thyroid disease and celiac disease, and mood disorders such as depression, suicidal ideation,
anxiety and eating disorders6. Studies have shown that early identification of psychiatric
disorders may improve diabetic treatment outcomes and improve quality of life27. Providers that
treat patients with intellectual disabilities should be especially cautious and take care to be
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providing all necessary screening for these patients to improve preventative medicine rates in
this population30. Usage of technologies such as tablets has improved the efficiency of screening
for comorbid conditions50. CMG and insulin pumps also improve care for patients who suffer
from psychiatric disorders like anxiety and depression because they simplify care,50. These
pumps are also programmable and have memory logs that providers can evaluate, which could
help avoid harmful behaviors such as insulin omission50. CGM improves glycemic control in
patients with autism who have trouble with self-management of T1D and have difficulty with
frequent in-person visits because of adverse interactions with hospital staff47. This improvement
in this population suggests that implementation of diabetic technology may have the ability to
improve health outcomes for patients with intellectual disabilities and those with comorbid
diseases but may be able to help prevent the progression of additional disorders or poor T1D
management, thus decreasing the risk for future diabetic-related complications. Efforts are
required to lower the cost of diabetic technology, improve insurance coverage, and encourage
providers to prescribe it to non-Hispanic White populations.
CONCLUSION:
Individuals of all age groups with T1D have increased morbidity and mortality rates than
the general population1,2,3,6. Patients diagnosed in childhood or adolescence have an even greater
risk for diabetic-related complications because the rates increase proportionally to the length of
time a patient has suffered from T1D1,2,3,6. Studies have shown that attaining individualized
glycemic control goals is correlated with less risk of both acute and chronic complications of
T1D1,2,3,6. Inadequate management of blood glucose levels can cause hypoglycemic episodes and
DKA and eventually leads to microvascular and macrovascular complications6. In order to
reduce diabetic-related complications in patients with T1D, providers and patients must address
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the factors that inhibit adequate glycemic control. Many studies have shown that psychosocial
factors can influence a

T1D

6,13,15,22,56.

The

increasing global incidence of T1D in children and adolescents, along with the decreasing
number of endocrinologists, indicates the importance of all providers understating how to
manage T1D, including identifying obstacles that impair patients with T1D from achieving
glycemic control. T1D is highly prevalent in the U.S. and has deadly consequences for patients.
The prevalence and intensity of the disease signify that facilitating the advancement towards
sufficiently managed diabetes will decrease healthcare costs to the U.S. economy and, most
importantly, allow millions of people to have an increased quality of life.
Glycemic control can improve with additional future research by including
underrepresented populations such as patients with T1D from ethnic and racial minorities, those
with intellectual disabilities, or those who identify as LGBTQ+. In particular, these studies
should examine how providers can improve access to healthcare through expanding
Telemedicine and the use of newer technologies, including CGM and insulin pumps, more
uniformly across all T1D populations to decrease diabetic-related complications. While there are
studies that expose these disparities, relatively few provide solutions to this problem. Technology
has the potential to improve glycemic control, so further research should also include strategies
to make diabetic technologies more prevalent in all populations, which may rely on reducing
costs and increasing awareness. Providers must advocate for more education regarding the
benefits of diabetic-technologies in managing T1D in adolescents. These efforts should also
include further advancements in the multidisciplinary approach by focusing research on how to
utilize varying healthcare providers and specialists T1D care effectively.
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Improving the quality of life for patients with diabetes relies heavily on improving
glycemic control during adolescence. According to the literature reviewed in this paper,
psychosocial factors have profound influences on the ability to attain glycemic control. The
mitigation of these factors involves improving healthcare access through systemic reform,
increased availability of health insurance, Telemedicine, language barriers, increasing education
and availability of diabetic technology, and implementing behavioral interventions to improve
self-management skills. Providers and healthcare systems must advocate for healthcare reform
that decreases systemic disparities between groups and improves the quality of healthcare for all
populations. Furthermore, individual behavioral interventions, familial therapies, and an
integrative diabetic care team have improved glycemic control. Technology such as insulinpumps, CGMs, closed-loops systems, and analytic data software also improves healthcare access
and quality of life in patients with T1D. Navigating through these factors to maintain glycemic
control in adolescence requires a team effort from the diabetic team, the patient, and their
caregivers.
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